LUPIN
Quarterly Results Analysis [Dec2023]
LUPIN Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹5,197 Cr | ₹5,039 Cr | ₹4,814 Cr | ₹4,430 Cr | ₹4,322 Cr | ₹4,146 Cr | ₹3,744 Cr | ₹3,883 Cr |
Expenses | ₹4,175 Cr | ₹4,121 Cr | ₹3,958 Cr | ₹3,852 Cr | ₹3,806 Cr | ₹3,693 Cr | ₹3,512 Cr | ₹3,615 Cr |
Operating Income | ₹1,022 Cr | ₹918 Cr | ₹856 Cr | ₹578 Cr | ₹516 Cr | ₹453 Cr | ₹232 Cr | ₹268 Cr |
Other Income | ₹45 Cr | ₹40 Cr | ₹23 Cr | ₹37 Cr | ₹35 Cr | ₹15 Cr | ₹6 Cr | ₹16 Cr |
Interest | ₹74 Cr | ₹81 Cr | ₹86 Cr | ₹93 Cr | ₹84 Cr | ₹55 Cr | ₹43 Cr | ₹41 Cr |
Depreciation | ₹257 Cr | ₹248 Cr | ₹235 Cr | ₹264 Cr | ₹220 Cr | ₹203 Cr | ₹193 Cr | ₹327 Cr |
Profit Before Tax | ₹736 Cr | ₹630 Cr | ₹559 Cr | ₹259 Cr | ₹246 Cr | ₹210 Cr | ₹2 Cr | ₹-85 Cr |
Profit After Tax | ₹619 Cr | ₹495 Cr | ₹453 Cr | ₹242 Cr | ₹158 Cr | ₹134 Cr | ₹-87 Cr | ₹-512 Cr |
EPS | ₹13.46 | ₹10.76 | ₹9.94 | ₹5.19 | ₹3.37 | ₹2.85 | ₹-1.96 | ₹-11.40 |
Industry Peers & Returns | 1W | 1M | 1Y |
LUPIN | 3.1% | -1.1% | 127.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
CIPLA | 4.5% | -3.1% | 52.8% |
DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
MANKIND PHARMA | 2.7% | 12.4% | NA |
TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
AUROBINDO PHARMA | 1.5% | 7.3% | 84.5% |
LUPIN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 3.15 % |
Y-o-Y | 20.25 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹5,197 Cr | 3.15 | |
Sep2023 | ₹5,039 Cr | 4.66 | |
Jun2023 | ₹4,814 Cr | 8.67 | |
Mar2023 | ₹4,430 Cr | 2.50 | |
Dec2022 | ₹4,322 Cr | 4.26 | |
Sep2022 | ₹4,146 Cr | 10.73 | |
Jun2022 | ₹3,744 Cr | -3.58 | |
Mar2022 | ₹3,883 Cr | - |
LUPIN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 11.35 % |
Y-o-Y | 98.04 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹1,022 Cr | 11.35 | |
Sep2023 | ₹918 Cr | 7.18 | |
Jun2023 | ₹856 Cr | 48.21 | |
Mar2023 | ₹578 Cr | 11.96 | |
Dec2022 | ₹516 Cr | 13.92 | |
Sep2022 | ₹453 Cr | 94.99 | |
Jun2022 | ₹232 Cr | -13.26 | |
Mar2022 | ₹268 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 7.96 % |
Y-o-Y | 64.66 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 19.66% | 7.96 | |
Sep2023 | 18.21% | 2.36 | |
Jun2023 | 17.79% | 36.43 | |
Mar2023 | 13.04% | 9.21 | |
Dec2022 | 11.94% | 9.24 | |
Sep2022 | 10.93% | 76.01 | |
Jun2022 | 6.21% | -10.00 | |
Mar2022 | 6.9% | - |
LUPIN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 24.91 % |
Y-o-Y | 292.45 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹619 Cr | 24.91 | |
Sep2023 | ₹495 Cr | 9.26 | |
Jun2023 | ₹453 Cr | 87.03 | |
Mar2023 | ₹242 Cr | 53.75 | |
Dec2022 | ₹158 Cr | 17.24 | |
Sep2022 | ₹134 Cr | Positive | |
Jun2022 | ₹-87 Cr | Negative | |
Mar2022 | ₹-512 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 21.06 % |
Y-o-Y | 226.03 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 11.9 % | 21.06 | |
Sep2023 | 9.83 % | 4.35 | |
Jun2023 | 9.42 % | 72.21 | |
Mar2023 | 5.47 % | 49.86 | |
Dec2022 | 3.65 % | 12.65 | |
Sep2022 | 3.24 % | Positive | |
Jun2022 | -2.32 % | Negative | |
Mar2022 | -13.18 % | - |
LUPIN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 25.09 % |
Y-o-Y | 299.41 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹13.46 | 25.09 | |
Sep2023 | ₹10.76 | 8.25 | |
Jun2023 | ₹9.94 | 91.52 | |
Mar2023 | ₹5.19 | 54.01 | |
Dec2022 | ₹3.37 | 18.25 | |
Sep2022 | ₹2.85 | Positive | |
Jun2022 | ₹-1.96 | Negative | |
Mar2022 | ₹-11.4 | - |
You may also like the below Video Courses